{"filing":{"accession_number":"0001628280-26-057387","cik":"0001822359","ticker":"DCGO","company_name":"DocGo Inc.","form":"8-K","filing_date":"2026-08-17","report_date":"2026-08-16","primary_document":"dcgo-20260816.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1822359/000162828026057387/dcgo-20260816.htm"},"events":[{"id":28289,"run_id":25864,"accession_number":"0001628280-26-057387","anchor_item_number":"1.01","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.98,"summary":"DocGo entered into a definitive Agreement and Plan of Merger to acquire Hicuity Health, a virtual care provider. The transaction involves DocGo's subsidiary merging with Hicuity, with Hicuity surviving as a wholly owned subsidiary, for consideration consisting of 2.0% of DocGo's fully diluted common stock at closing plus up to 3.5% contingent earnout shares, plus assumption of approximately $52 million in existing indebtedness.","company_name":"DocGo Inc.","ticker":"DCGO","filing_date":"2026-08-17","form":"8-K","submitted_at":null,"items":[{"id":30184,"accession_number":"0001628280-26-057387","item_number":"1.01","item_title":"Entry Into a Material Definitive Agreement.","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.98,"reasoning":"DocGo has entered into a definitive Agreement and Plan of Merger to acquire Hicuity Health, a virtual care provider. The transaction involves DocGo's subsidiary merging with Hicuity, with Hicuity surviving as a wholly owned subsidiary. The consideration consists of 2.0% of DocGo's fully diluted common stock at closing plus up to 3.5% contingent earnout shares, plus assumption of approximately $52 million in existing indebtedness. This is a material acquisition that would significantly affect investor assessment of the registrant's strategic direction, financial position, and future prospects.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-17T20:25:45.091059+00:00","company_name":"","ticker":null,"filing_date":""}]},{"id":28290,"run_id":25864,"accession_number":"0001628280-26-057387","anchor_item_number":"2.02","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"summary":"DocGo announced Q2 2026 earnings results (ended June 30, 2026) reporting total revenue of $73.4 million, net loss of $18.0 million, and adjusted EBITDA of ($6.3) million, along with revised full-year 2026 guidance.","company_name":"DocGo Inc.","ticker":"DCGO","filing_date":"2026-08-17","form":"8-K","submitted_at":null,"items":[{"id":30185,"accession_number":"0001628280-26-057387","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"The Item 2.02 disclosure announces DocGo's earnings results for Q2 2026 (ended June 30, 2026) via a press release furnished as Exhibit 99.1. The press release reports total revenue of $73.4 million, net loss of $18.0 million, and adjusted EBITDA of ($6.3) million, along with revised full-year 2026 guidance. This is a standard quarterly earnings announcement material to investors assessing the company's financial performance.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-17T20:25:45.091059+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":30184,"accession_number":"0001628280-26-057387","item_number":"1.01","item_title":"Entry Into a Material Definitive Agreement.","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.98,"reasoning":"DocGo has entered into a definitive Agreement and Plan of Merger to acquire Hicuity Health, a virtual care provider. The transaction involves DocGo's subsidiary merging with Hicuity, with Hicuity surviving as a wholly owned subsidiary. The consideration consists of 2.0% of DocGo's fully diluted common stock at closing plus up to 3.5% contingent earnout shares, plus assumption of approximately $52 million in existing indebtedness. This is a material acquisition that would significantly affect investor assessment of the registrant's strategic direction, financial position, and future prospects.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-17T20:25:45.091059+00:00","company_name":"DocGo Inc.","ticker":"DCGO","filing_date":"2026-08-17"},{"id":30185,"accession_number":"0001628280-26-057387","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"The Item 2.02 disclosure announces DocGo's earnings results for Q2 2026 (ended June 30, 2026) via a press release furnished as Exhibit 99.1. The press release reports total revenue of $73.4 million, net loss of $18.0 million, and adjusted EBITDA of ($6.3) million, along with revised full-year 2026 guidance. This is a standard quarterly earnings announcement material to investors assessing the company's financial performance.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-17T20:25:45.091059+00:00","company_name":"DocGo Inc.","ticker":"DCGO","filing_date":"2026-08-17"}]}